What are the recommendations for using throat lozenges for sore throat relief?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Throat Lozenges for Sore Throat Relief

Throat lozenges containing NSAIDs (specifically flurbiprofen 8.75 mg) or local anesthetics (lidocaine 8 mg, benzocaine 8 mg, or ambroxol 20 mg) are effective first-line treatments for acute sore throat, providing rapid symptom relief within 1-15 minutes of administration. 1, 2, 3

Recommended Lozenge Types

NSAID-Containing Lozenges (Most Effective)

  • Flurbiprofen 8.75 mg lozenges are the most evidence-based lozenge option, demonstrating superior efficacy over placebo for throat pain, difficulty swallowing, and swollen throat sensation 1, 2
  • Provide 79.8% greater relief for sore throat pain, 99.6% for difficulty swallowing, and 69.3% for swollen throat over 24 hours compared to placebo 2
  • Particularly effective in patients with moderate-to-severe symptoms and evidence of pharyngeal inflammation 2
  • Can be used up to 5 lozenges per 24 hours, taken every 3-6 hours as needed 2

Local Anesthetic Lozenges (Alternative Option)

  • Lidocaine 8 mg, benzocaine 8 mg, or ambroxol 20 mg lozenges are confirmed effective alternatives with rapid onset of action 3
  • Ambroxol 20 mg has the best documented benefit-risk profile among local anesthetics for acute sore throat 3
  • AMC/DCBA + lidocaine lozenges provide rapid onset from 1-10 minutes post-dose, with peak numbness at 15 minutes 4
  • Hexylresorcinol lozenges demonstrate onset from 1-5 minutes post-dose, with peak numbness at 10 minutes 4

Treatment Algorithm

First-Line Approach

  • Start with oral systemic analgesics (ibuprofen or paracetamol) as primary treatment, following recommended dosing guidelines 1, 5
  • Add flurbiprofen lozenges for additional local relief when systemic analgesics alone are insufficient 1, 2
  • Consider local anesthetic lozenges (ambroxol preferred) if NSAID lozenges are contraindicated or unavailable 3

Dosing Strategy

  • Use lozenges every 3-6 hours as needed, maximum 5 lozenges per 24 hours 2
  • Allow lozenge to dissolve slowly in mouth for optimal local effect 4
  • Continue treatment for typical sore throat duration of less than 1 week 1

Important Cautions and Pitfalls

What NOT to Recommend

  • Avoid local antibiotics or antiseptics - these lack efficiency data and are not indicated for predominantly viral sore throat 3
  • Zinc gluconate lozenges are not recommended for sore throat treatment despite use in common cold symptoms 1, 5
  • Herbal remedies and acupuncture have inconsistent evidence and should not be recommended as primary treatment 1, 5
  • Most AMC/DCBA or hexylresorcinol lozenges show minimal antiviral activity against respiratory viruses causing sore throat 6

Safety Considerations

  • Flurbiprofen lozenges are well-tolerated with no serious or unexpected adverse events in clinical trials 2
  • Use standard NSAID contraindications when recommending flurbiprofen lozenges 2
  • Both NSAID and local anesthetic lozenges have favorable safety profiles for short-term use 4, 3

Clinical Context

  • Remember that antibiotics provide minimal benefit - they only shorten sore throat duration by 1-2 days with number needed to treat of 6 at 3 days and 21 at 1 week 1
  • Most sore throats are viral and self-limiting, resolving within 7 days 1, 7
  • Lozenges provide symptomatic relief but do not alter disease course 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Pharmacy based sore throat therapy according to current guidelines].

Medizinische Monatsschrift fur Pharmazeuten, 2015

Research

Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4-dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2012

Guideline

Sore Throat Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Sore Throat - Guideline-based Diagnostics and Therapy].

ZFA. Zeitschrift fur Allgemeinmedizin, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.